These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 865132)

  • 21. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
    Marks LS; Maxwell MH; Gross C; Waks U; Kaufman JJ
    Br J Urol; 1977 Jun; 49(3):181-8. PubMed ID: 334316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade by saralasin of adrenergic potentiation induced by renin-angiotensin system.
    Zimmerman BG; Kraft E
    J Pharmacol Exp Ther; 1979 Jul; 210(1):101-5. PubMed ID: 448637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH; Dalakos TG; Anderson GH
    Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immediate pressor effect of saralasin in man.
    Carey RM; Vaughan ED; Ackerly JA; Peach MJ; Ayers CR
    J Clin Endocrinol Metab; 1978 Jan; 46(1):36-43. PubMed ID: 752023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the activity of the sympathetic nervous system in essential hypertension.
    Chobanian AV; Garvras H; Gavras I; Bresnahan M; Sullivan P; Melby JC
    J Human Stress; 1978 Sep; 4(3):22-8. PubMed ID: 690418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
    Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
    J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 37. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM; Wilson JP; Slaton PE; Foster JH; Liddle GW; Hollifield JW
    Ann Intern Med; 1977 Jul; 87(1):36-42. PubMed ID: 879617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.